Charles River Labs ( (CRL) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Charles River Labs’ stock has been on the move due to Barclays upgrading the company to an Overweight rating. This upgrade comes as a result of stabilized drug discovery demand and improved valuations, hinting at a potential upside in earnings estimates. However, recent leadership transitions and market challenges have also influenced market perceptions.
More about Charles River Labs
YTD Price Performance: -6.66%
Average Trading Volume: 891,585
Technical Sentiment Signal: Hold
Current Market Cap: $8.39B
For further insights into CRL stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.